secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0001104659-25-065979
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira enters $300M revolving credit facility, replaces prior term loan A
-------------------------------------------------------------------------

- $300M senior secured revolver matures July 3, 2030; includes $10M LC sublimit and $15M swingline.
- Proceeds used to repay and terminate existing term loan A facility; no prepayment penalties.
- Interest rates: SOFR + 2.50%-3.25% or base rate + 1.50%-2.25%, based on leverage ratio.
- Facility secured by substantially all assets of Pacira and subsidiary guarantors.
- Incremental facility capacity up to greater of $225M or 100% Consolidated EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/0001104659-25-065979-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/tm2519804d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-065979

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer